Rash ID is an AI-powered skin analysis tool for iOS and Android that combines image scanning with symptom reporting to identify dermatological conditions.
Product velocity
Maintenance
Daily rank 🇺🇸
#60
▲1Medical · grossing
Sentiment
4.4
355 reviews
Nemesis
Fragmented field
The App DNA
What makes this app unique?
Users hire the app to gain immediate, preliminary clarity on skin concerns, reducing the uncertainty of self-diagnosis before seeking professional medical advice.
For Individuals seeking immediate, preliminary information about skin concerns or rashes to inform their next steps before consulting a healthcare professional.
What does it look like?
Key features
Combines image recognition with user-provided symptom descriptions.
Conversational assistant that asks targeted questions and explains reasoning.
Saves images and logs to monitor skin changes.
How much does it cost?
The freemium model uses a single free-scan trial to demonstrate utility before gating the advanced conversational AI behind a subscription.
Velocity
Maintenance developmentUX improvementsnew contentShow more...
The app has released two versions within a three-day window in early 2026, but there is no evidence of releases in the preceding months, resulting in a maintenance-level cadence. Development is currently focused on core UX improvements and feature expansion, specifically regarding scan history management and user-personalized routines. The recent updates represent a shift toward enhancing the primary scanning workflow and user engagement tools. Future momentum remains to be seen as the current release pattern does not yet indicate a consistent, high-frequency development cycle.
Who built it?
Appsmiths
4 apps tracked · Medical
PLNR : To-Do List + Calendar
Today: Collaborate & Grow
Eli: Self-Discovery & FaithUser Sentiment
What do users think recently?
Recent user voice shows an upset sentiment. Users appreciate accurate identification of skin conditions provides medical value for some users, but report subscription paywalls appearing before any functional scan results are provided.
How are ratings & reviews evolving?
What users say, by theme
- Accurate identification of skin conditions provides medical value for some users
- Subscription paywalls appearing before any functional scan results are provided
65 of 74 recent reviews analyzed · high confidence · Upset overall
Read the full review analysisUnlock 1 more frustration theme and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Rash ID: Skin Rash Identifier
How's the Medical market?
Rash ID occupies a niche in the Medical category, but its grossing rank volatility across international markets (e.g., #30 in AE, #21 in IE) suggests an unstable revenue base. The high frequency of technical complaints relative to its 4.45 average rating indicates that current growth is driven by curiosity rather than long-term utility.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Rash ID: Skin Rash Identifier
Where is it heading?
The medical-AI market is consolidating around tools that provide verifiable clinical support, leaving Rash ID exposed due to its reliance on unverified consumer-facing diagnostics. Unless the team resolves the core scan failures and shifts to a more user-friendly monetization model, the app will continue to lose ground to more stable, multi-functional health platforms.
- Technical scan failures in the latest release prevent usable output, which compounds the rating drag already visible on Android.
- The subscription-first monetization model alienates new users, leading to high churn and negative sentiment regarding the app's transparency.
The SWOT
- Dual-input analysis mechanism differentiates from static image-only scanners
- Secure, HIPAA-compliant data processing builds user trust
- Implement pay-per-use model for infrequent users
- Expand library to include more chronic condition tracking
Next best moves
Pivot monetization to pay-per-use because subscription paywalls trigger high churn → increase conversion rate
+ 1 more prioritized moveThe counter-intuitive read
The app's high grossing rank in new markets is a liability…
Read the full takeFeature gaps
Peer-reviewed clinical image library (available in VisualDx but absent here) +1
Since the last report: The app introduced new engagement features like scan history and routines, but core diagnostic utility remains hampered by technical scan failures and a restrictive subscription-first monetization model.
Bottom line
Rash ID provides a unique dual-input diagnostic tool, but the aggressive paywall and technical instability alienate the user base, so the team must prioritize scan reliability and a more flexible monetization model to prevent further churn.
Unlock 3 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated